1. Dr. Rajeev Agarwala Jaswant Rai Speciality Hospital, Meerut. E-mail : [email protected] HOW TO CHOOSE YOUR BRIDE AMONG THREE SISTERS 2. 4. Plaque rupture, cholesterol…

1. Beyond Framingham: Contemporary Evolution ofIndividualized Coronary Heart Disease Risk Assessment Jeffrey L. Anderson, MDProfessor of Medicine, University of Utah Associate…

1. Dr. Rajeev Agarwala Jaswant Rai Speciality Hospital, Meerut. E-mail : [email protected] HOW TO CHOOSE YOUR BRIDE AMONG THREE SISTERS 2. 4. Plaque rupture, cholesterol…

Slide 1Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-controlled Trials: The Cross Trial Safety Analysis Scott D. Solomon, MD, Janet Wittes, PhD, Ernest Hawk, MD,…

Slide 1Professor Michel KOMAJDA Université Pierre & Marie Curie – Hôpital Pitié Salpêtrière Département de Cardiologie Paris (France) Future perspectives in Heart…

Slide 1The Anglo-Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm (ASCOT-BPLA) Blood Pressure Variability and Cardiovascular Outcomes PS Sever, PM Rothwell,…

Slide 11464 Mo Renin inhibitors: the last challenge in the RAAS blockade Alberto Morganti U.O. Medicna Generale e Centro Ipertensione Arteriosa Ospedale San Giuseppe Unversità…

Slide 1The ABCs of the AHA/ACC Prevention Guidelines Alessandra Calvo-Friedman, Andrew DeFilippis, MD, Ty Gluckman MD, Dominique Ashen, CRNP, PhD, Roger Blumenthal, MD, Johns…

Slide 1 Slide 2 Slide 3 “Real World”: SVG, De Novo or Restenotic Coronary Artery Lesions Chronic Stable Angina, Silent Ischemia, Acute Coronary Syndromes Vessel Diameters:…

1.Appropriateness Criteria for Revascularization – Making sense of the recommendations Dr. Lalit KapoorChief Cardiac Surgeon Apollo Hospital, Ranchi www.heartsurgery.in2.…